<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The prognosis of germinal center-derived B-cell (GCB) <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, including follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and diffuse large-B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>), strongly depends on age </plain></SENT>
<SENT sid="1" pm="."><plain>Children have a more favorable outcome than adults </plain></SENT>
<SENT sid="2" pm="."><plain>It is not known whether this is because of differences in host characteristics, treatment protocols, or <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> biology, including the presence of chromosomal alterations </plain></SENT>
<SENT sid="3" pm="."><plain>By screening for novel IGH translocation partners in pediatric and adult <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, we identified chromosomal translocations juxtaposing the IRF4 oncogene next to one of the immunoglobulin (IG) loci as a novel recurrent aberration in mature B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>FISH revealed 20 of 427 <z:hpo ids='HP_0002665'>lymphomas</z:hpo> to carry an IG/IRF4-fusion </plain></SENT>
<SENT sid="5" pm="."><plain>Those were predominantly GCB-type <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> or follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> grade 3, shared strong expression of IRF4/MUM1 and BCL6, and lacked PRDM1/BLIMP1 expression and t(14;18)/BCL2 breaks </plain></SENT>
<SENT sid="6" pm="."><plain>BCL6 aberrations were common </plain></SENT>
<SENT sid="7" pm="."><plain>The gene expression profile of IG/IRF4-positive <z:hpo ids='HP_0002665'>lymphomas</z:hpo> differed from other subtypes of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>A classifier for IG/IRF4 positivity containing 27 genes allowed accurate prediction </plain></SENT>
<SENT sid="9" pm="."><plain>IG/IRF4 positivity was associated with young age and a favorable outcome </plain></SENT>
<SENT sid="10" pm="."><plain>Our results suggest IRF4 translocations to be primary alterations in a molecularly defined subset of GCB-derived <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>The probability for this subtype of <z:hpo ids='HP_0002665'>lymphoma</z:hpo> significantly decreases with age, suggesting that diversity in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> biology might contribute to the age-dependent differences in prognosis of <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
</text></document>